Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Genitourinary 2Thoracic 1Other solid neoplasm 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Sarcoma 39Dendritic Cell Sarcoma, Interdigitating 30Lymphoma 22Burkitt Lymphoma 22Lymphoma, Large B-Cell, Diffuse 20Osteosarcoma 17Neuroectodermal Tumors, Primitive, Peripheral 17Lymphoma, Non-Hodgkin 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Leukemia 15Lymphoma, Large-Cell, Immunoblastic 14Lymphoma, Mantle-Cell 12Lymphoma, Follicular 12Leukemia, Myeloid, Acute 12Leukemia, Lymphocytic, Chronic, B-Cell 12Rhabdomyosarcoma 11Lymphoma, B-Cell, Marginal Zone 11Sarcoma, Ewing 10Recurrence 10Neuroblastoma 10Blast Crisis 10Leukemia, Myeloid, Accelerated Phase 9Central Nervous System Neoplasms 9Neoplasms, Plasma Cell 8Myelodysplastic Syndromes 8Multiple Myeloma 8Leukemia, Myeloid, Chronic-Phase 8Hodgkin Disease 8Brain Neoplasms 8Myeloproliferative Disorders 7

Interventions

Ibandronic Acid 8Gemcitabine 8Doxorubicin 6Cyclophosphamide 6Zoledronic Acid 5Radiation 4Nivolumab 4Irinotecan 4pembrolizumab 3Vincristine 3Temozolomide 3Magnetic Resonance Spectroscopy 3Ipilimumab 3Docetaxel 3Denosumab 3Cisplatin 33-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 3regorafenib 2pegfilgrastim 2Tranexamic Acid 2Trabectedin 2Surveys and Questionnaires 2Sunitinib 2Standard of Care 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Radiosurgery 2Quality of Life 2Proton Therapy 2Observation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Bone Neoplasms × Etoposide × Sarcoma × Clear all
NCT03420963 2026-03-20

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Terminated
12 enrolled
DermatologicGenitourinaryHead & NeckOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Bone Neoplasms, Endocrine Gland Neoplasms, Melanoma, Mouth Neoplasms, Pharyngeal Neoplasms, Sarcoma, Skin Neoplasms, Thyroid Neoplasms, Urologic Neoplasms

NCT00960063 2018-08-27

A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)

Merck Sharp & Dohme LLC

Phase 1 Terminated
4 enrolled 8 charts
CNSGenitourinarySarcoma

Bone Neoplasms, Carcinoma, Renal Cell, Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡